Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #121
- Final score
- 64.91
- Years on list
- 6
↗ Climbed 35 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 35 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 162 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 26 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | TMO | MTD | A |
|---|---|---|---|
| Climate Change | 80.9 | 83.4 | 76.5 |
| Employee Relations | 49.6 | 44.1 | 56.1 |
| Environment | 74.0 | 69.2 | 75.2 |
| Stakeholders & Society | 61.7 | 77.4 | 72.7 |
| Human Rights | 58.1 | 54.7 | 47.4 |
| Governance | 55.9 | 61.5 | 45.7 |
| Performance Rating | 62.8 | 57.8 | 56.4 |